Nordson Corporation · NASDAQ:NDSN
Nordson — Q4 2022 Earnings Presentation
16 slides from Nordson's earnings presentation, Dec 15, 2022
Slide 1: 4Q & Full-Year Fiscal 2022 Webcast
4Q & Full-Year Fiscal 2022 Webcast December 15, 2022 NBS NEXT OWNER MINDSET WINNING TEAMS
Slide 2: Safe Harbor Statement
Safe Harbor Statement Click to edit title Under the Private Securities Litigation Reform Act of 1995 Certain statements contained in this release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by
Slide 3: Agenda
Agenda 4Q and Full-Year Fiscal 2022 Webcast – December 15, 2022 § Fourth Quarter and Full-Year Highlights § Sales Performance and Earnings Review § Balance Sheet and Cash Flow § Enterprise Performance § FY 2023 and 1Q 2023 Outlook and Guidance § Q&A Sundaram Nagarajan Joseph Kelley Lara Mahoney Pres
Slide 4: Highlights
Highlights § Record performance despite macro-economic factors Strong execution and NBS Next driving record results § Second consecutive year of record results § NBS Next growth framework is a working model, becoming competitive advantage 4
Slide 5: Total Company – 4Q 2022
Total Company – 4Q 2022 4Q 2022 Sales Bridge Sales $23 $107 $684 § 14% sales growth, inclusive of 18% organic growth $599 $(46) plus the NDC acquisition, offset by 8% impact of unfavorable currency § Organic sales increase 14% volume and 4% pricing § Growth in all geographies and most product lines,
Slide 6: Total Company – Fiscal 2022
Total Company – Fiscal 2022 Full Year Sales Bridge Record Annual Sales $255 $78 $2,590 § Annual sales of $2.6 billion, an increase of 10% $2,362 $(104) § Organic growth increased 11% with NDC acquisition contributing 3%. This was offset by unfavorable currency impact of 4%. § Broad-based growth acro
Slide 7: Industrial Precision Solutions – 4Q 2022
Industrial Precision Solutions – 4Q 2022 4Q 2022 IPS Sales Bridge Sales $23 § 13% sales increase $49 $356 $(30) § 16% organic growth; 7% acquisition; 10% unfavorable $314 currency impact § Robust demand in polymer processing product lines, plus steady growth in consumer non-durable and industrial en
Slide 8: Medical and Fluid Solutions – 4Q 2022
Medical and Fluid Solutions – 4Q 2022 4Q 2022 MFS Sales Bridge Sales $24 § Sales increased 11% $181 $(6) § 15% organic growth; 4% unfavorable currency impact $164 § Growth across all product lines, particularly biopharma fluid components 4Q 2021 Organic Currency 4Q 2022 Operating Profit Operating Pr
Slide 9: Advanced Technology Solutions – 4Q 2022
Advanced Technology Solutions – 4Q 2022 4Q 2022 ATS Sales Bridge Sales $34 $147 § Sales increased 21% $121 $(9) § 28% organic growth; 7% unfavorable currency impact § Double-digit growth in both T&I and electronics dispense product lines 4Q 2021 Organic Currency 4Q 2022 Operating Profit Operating Pr
Slide 10: Balance Sheet and Cash Flow
Balance Sheet and Cash Flow Strong Cash Flow with Sufficient Liquidity to Invest in Strategic Initiatives Net Debt Free Cash Flow § Cash totaled $163 million § Conversion rate of 90% of net income § 0.7 net debt leverage ratio based on trailing 12-month § Strategic investments in inventory EBITDA Ne
Slide 11: Looking forward
§ NBS Next growth framework Looking forward creates competitive advantage NBS Next combined with core § Customer-centric business capabilities position Nordson well model § Diversified geographies and end markets § Over 50% recurring revenue § Disciplined M&A strategy adds precision technology 11
Slide 12: 2023 Fiscal Full-Year Guidance
2023 Fiscal Full-Year Guidance Full-Year Sales Guidance $2,616 - $2,772 Full-Year Growth from Record 2022 $2,362 $2,590 § NBS Next Deployment throughout the business is advancing and delivering results § Backlog, including CyberOptics, is ~$1 billion § Fiscal 2023 sales growth of ~1 – 7% § Adjusted
Slide 13: 2023 Fiscal 1Q Guidance
2023 Fiscal 1Q Guidance 1Q 2023 Sales Guidance Steady performance moving into 1Q $609 $605 - $630 $527 § 1Q 23 sales of $605 - $630 million § 1Q 23 adjusted earnings per share in the range of $1.85 - $2.00 § Assumes negative currency impact of ~4% on sales and ~7% on earnings 1Q 21 1Q 22 1Q 23 1Q 20
Slide 14: Questions?
Questions? CGordson
Slide 15: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures Adjusted Operating Profit and EBITDA (Dollars in thousands) 15
Slide 16: Reconciliation of Non-GAAP Measures
Reconciliation of Non-GAAP Measures Profitability (Dollars in thousands) 16